Patient perceptions of a mobile cancer support unit in South Wales

Abstract

Many patients have to travel long distances to receive treatment and support for cancer, which can lead to increased anxiety and fatigue. Tenovus, the cancer charity, working with the NHS, has developed a new concept of closer-to-home delivery for chemotherapy and other cancer support - a mobile cancer support unit (Bus). Researchers at Cardiff University evaluated the Bus during its first year of operation. The evaluation aimed to determine who was using the Bus and to explore patients' perceptions about having their appointments on the Bus. Data were collected from patients, social care clients and their family and friends using a mixed-methods approach. Quantitative data were collected using postal surveys and qualitative data were collected through semi-structured interviews. In its first year, 3487 people visited the Bus, which included the delivery of 549 chemotherapy treatments. Patient attitudes towards the Bus were extremely positive. Respondents rated highly key aspects of the Bus including comfort and the level of care provided. This evaluation demonstrates that all users are highly receptive to this model of service delivery and agree that the Tenovus Bus is a unique mobile unit, providing excellent clinical and social care to cancer patients and their families.

Pilot evaluation of home delivery programme in haemophilia

“…Homecare service is a model of healthcare delivery that has expanded rapidly in recent years in other countries, such as the UK, but it remains very uncommon in Spain . A medicine homecare delivery service can be described as one that delivers ongoing medicinal supplies and, where necessary, associated care, initiated by a hospital prescriber direct to a patient's home with his/her consent.…”

A Literature Review on Attitudes of Health Professionals towards Health Information Systems: From e-Health to m-Health

“…In this case, it is a need to figure the influencing factors for mobile health services in order to assess the effective use of the services. Literature provided that recent studies aimed to investigate the acceptance of mobile health services including management systems for patients and professionals [17][18][19][20][21][22][23][24].…”

Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment

“…A number of programs have implemented mobile services including for opioid addiction using LAAM, 50 methadone, 51-53 HIV education and testing, 54 HIV treatment, 55 for mental health services 56 and for cancer information and support. 57,58 In two MAT studies that are most relevant to the current trial which implemented LAAM and Methadone, findings were supportive of mobile treatment with a risky opioid dependent population. In the Kou et.…”